P. You

发表

Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan

N. El-Bassel, A. Terlikbayeva, N. Schluger, 2017, PloS one.

Application of PCR‐LDR‐nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine

F. Lu, Q. You, Huayan Zhong, 2010, Journal of medical virology.

Racial disparities in the use of programmed death-1 checkpoint inhibitors.

A. Abernethy, C. Gross, A. Chiang, 2017 .

Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.

C. Gross, J. Ross, K. Carson, 2018, The oncologist.

Author’s Response to “A Letter in Support of Real-World RECIST”

S. Khozin, D. Schrag, S. Griffith, 2020, Advances in Therapy.

Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

Sandra D Griffith, Rebecca A Miksad, Geoff Calkins, 2019, JCO clinical cancer informatics.

Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer

S. Khozin, D. Schrag, S. Griffith, 2019, bioRxiv.

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

A. Abernethy, S. Griffith, Michael D. Taylor, 2018, Health Services Research.

Point-of-care diagnostic tests for low-resource settings.

R. Peeling, D. Mabey, P. Garcia, 2015, The Lancet. Global health.